Clinical Trial Update: Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trastuzumab in combination with lapatinib or pertuzumab in combination with trastuzumab-emtansine for HER2-positive metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)
• Trastuzumab emtansine (ado-trastuzumab emtansine)

Snippet

Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN